Enter to open, tab to navigate, enter to select
Recro Pharma, Inc. acquisition of equity interests of Alkermes Gainesville LLC and subsidiary equity interests of Alkermes Ireland Holdings Limited
| March 07, 2015 • Private Acquisition Agreements • $50 million (plus a warant to purchase 350,000 shares of Recro Pharma, Inc. common stock and subject to purchase price adjustment and additional earn-out payment). |
End of Document
© 2024 Thomson Reuters. No claim to original U.S. Government Works.